accelevirdx.com

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
# START YOAST BLOCK # --------------------------- User-agent: * Disallow: Sitemap: https://www.accelevirdx.com/sitemap_index.xml # --------------------------- # END YOAST

Meta Tags

Title	Home -
Description	Detecting ultra-rare targets for infectious disease and info@accelevir.com Start Your Project About Us Team Collaborators Services Clinical Solutions COVID-19 Testing Infectious Disease Comparator Testing Indus
Keywords	N/A

Server Information

WebSite	accelevirdx.com
Host IP	185.230.63.107
Location	-

Related Websites

                        Site
                        Rank
                    

More to Explore

accelevirdx.com Valuation

US$2,336,945

Last updated: 2023-05-12 01:15:30

accelevirdx.com has Semrush global rank of 4,529,120. accelevirdx.com has an estimated worth of US$ 2,336,945, based on its estimated Ads revenue. accelevirdx.com receives approximately 269,648 unique visitors each day. Its web server is located in -, with IP address 185.230.63.107. According to SiteAdvisor, accelevirdx.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$2,336,945
Daily Ads Revenue	US$2,158
Monthly Ads Revenue	US$64,716
Yearly Ads Revenue	US$776,585
Daily Unique Visitors	17,977
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
accelevirdx.com.	A	3600	IP: 185.230.63.107
accelevirdx.com.	A	3600	IP: 185.230.63.186
accelevirdx.com.	A	3600	IP: 185.230.63.171
accelevirdx.com.	NS	21600	NS Record: ns7.wixdns.net.
accelevirdx.com.	NS	21600	NS Record: ns6.wixdns.net.

HtmlToTextCheckTime:2023-05-12 01:15:30

info@accelevir.com Start Your Project About Us Team Collaborators Services Clinical Solutions COVID-19 Testing Infectious Disease Comparator Testing Industry Partnering Solutions Clinical and Discovery Research Clinical Trials Companion Diagnostic Partnering Technologies Digital PCR & Specialty HIV-1 Persistence Assays Specialty Virology Services Next-Generation Sequencing Comparator Testing Academic & Non-Profit News Room Recent News Publications Detecting ultra-rare targets for infectious disease and beyond. Clinical Trials Scientific-Based Novel Assays We develop innovative assays enabling novel therapeutic discovery to improve human health. Learn More Integrating digital PCR, specialized virology expertise, high-throughput automated workflows, culture-based approaches, and a CLIA laboratory to develop scalable and reproducible assays. Our assays for target quantitation are critical components of cure programs for HIV-1 and infectious diseases. Accelevir and their collaborators

HTTP Headers

HTTP/1.1 301 Moved Permanently
Date: Tue, 23 Nov 2021 08:41:13 GMT
Content-Length: 0
Connection: keep-alive
location: https://www.accelevirdx.com/
strict-transport-security: max-age=120
x-wix-request-id: 1637656873.22415815883171230497
Age: 0
Server-Timing: cache;desc=miss, varnish;desc=miss, dc;desc=42
X-Seen-By: 6ivkWfREES4Y8b2pOpzk7Owfbs+7qUVAqsIx00yI78k=,sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkVgjB5iMgVduhJkO1xgMq9zO,m0j2EEknGIVUW/liY8BLLqymrWSBpMfJbY0ZWU2hO35/HubKAh1QhTB6OuUXtTGV,2d58ifebGbosy5xc+FRalqbB6lb/zpf5DgrE/dr/Ii9d/DAlMSZ2hr6wLlZufs39XKN9oBQakyVJ4hwk4aTFKw==,2UNV7KOq4oGjA5+PKsX47LsZt2IrVMtH4UUk1T8GK3UfbJaKSXYQ/lskq2jK6SGP,9ADrBGWMd7SJ6/J4kjOvbYIxshLNKYOMlsRli78+V/Y=,qJS91GsscGZlb16v+8nwmHH/hP19U3vLGdIiVYguh/QPUN6zYCeYUhP+LoeE7OiY,9bmvtgOsMBj+rhOGTJK8fhDJfnB7NzOGtWxVMjvnHOupDeeeZozLReA9wgIRvIRehVHevACDb0AzzCn8e2G6mA==
Cache-Control: no-cache
X-Content-Type-Options: nosniff

HTTP/2 200 
date: Tue, 23 Nov 2021 08:41:13 GMT
content-type: text/html; charset=UTF-8
link: ; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,
x-wix-request-id: 1637656873.6269106064612180
content-language: en
strict-transport-security: max-age=120
age: 0
x-seen-by: GXNXSWFXisshliUcwO20NXdyD4zpCpFzpCPkLds0yMfq3yLedS/qRoYkJDnCZFa0,qquldgcFrj2n046g4RNSVI5y0OKACGwHEq+Bmxf53RlYgeUJqUXtid+86vZww+nL,2d58ifebGbosy5xc+FRaluqot46Bhe4Vk2Y8qEkw1bl8ZCrUIMmBd3xOVRWPNK1SSf524lPwTgDbn82fURSkbsT/YSwaEjIJvtrStZA1+JI=,2UNV7KOq4oGjA5+PKsX47EPxNtZAQGoUGD8v2MHQKAJYgeUJqUXtid+86vZww+nL,mRzpGPiujncGeOh+KUpXFeeLDPlMEcKCAVKH7bMpzFo=,9bmvtgOsMBj+rhOGTJK8fmbsq4Oxbpn6Xzb7pBcsplnOPfYv9dMWVzOYljINp3vPBFNjNRTmQgt5BwMmIVG00A==,qQbTLsvPZVUXp9HeAm/lzGkzzNctMGOqQ7viWhxrwMFGp/J3MBzgzU8QHrQuh4zQ,dvEkI3CoQ26/kOBf/eu3DKQXUCh574FPgaumobe8975YgeUJqUXtid+86vZww+nL,LoUK8/saGAmOxZWtpubo2ih/yuspSmU/rnM78s9f9CVNHPWmLIumvGVzwn0S7pYIceO+I/bfJFUDDUigClTSLw==,dvEkI3CoQ26/kOBf/eu3DKQXUCh574FPgaumobe8975YgeUJqUXtid+86vZww+nL,qJS91GsscGZlb16v+8nwmBymKac7LT3YShoNLWOwAnsPUN6zYCeYUhP+LoeE7OiY,/a5ccLSK1HEmwPNg/x6OunIjh3HBRtWAuzgqgNRcO7SQwmbskeMO0FoQXyPluTKeW52FBKt9bJ5mgpS0MU7HAg==
cache-control: no-cache
vary: Accept-Encoding
accept-ranges: bytes
set-cookie: ssr-caching=cache#desc=miss#varnish=miss#dc#desc=usc1_g; Max-Age=20; Expires=Tue, 23 Nov 2021 08:41:33 GMT
server-timing: cache;desc=miss, varnish;desc=miss, dc;desc=usc1_g
x-content-type-options: nosniff
server: Pepyaka/1.19.10
via: 1.1 google
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"

accelevirdx.com Whois Information

Domain Name: ACCELEVIRDX.COM
Registry Domain ID: 1947922373_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.1api.net
Registrar URL: http://www.1api.net
Updated Date: 2021-07-20T07:38:24Z
Creation Date: 2015-07-19T21:30:12Z
Registry Expiry Date: 2022-07-19T21:30:12Z
Registrar: 1API GmbH
Registrar IANA ID: 1387
Registrar Abuse Contact Email: abuse@1api.net
Registrar Abuse Contact Phone: +49.68949396850
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS6.WIXDNS.NET
Name Server: NS7.WIXDNS.NET
DNSSEC: unsigned
>>> Last update of whois database: 2021-11-23T07:55:07Z <<<

accelevirdx.com valuation and analysis